The effect of gene polymorphism interaction on modifiable risk factors for myocardial infarction

被引：0
|
作者：
Saber-Ayad, M. [1 ]
Taher, E. [2 ]
Latif, I. [1 ]
Mokhtar, S. [3 ]
Shafy, S. [2 ]
机构：
[1] Cairo Univ, Dept Pharmacol, Cairo, Egypt
[2] Cairo Univ, Community Dept, Cairo, Egypt
[3] Cairo Univ, Crit Care Dept, Cairo, Egypt
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：319 / 319
页数：1
相关论文
共 50 条
  • [21] Frequency of Modifiable Risk Factors at the Time of Myocardial Infarction and at Twelve Months Follow Up
    Ahmad, Shafique
    Ahmad, Shehzad
    Kashif, Mohammad
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2012, 6 (03): : 779 - 782
  • [22] No standard modifiable cardiovascular risk factors in acute myocardial infarction: prevalence, pathophysiology, and prognosis
    Saito, Yuichi
    Tsujita, Kenichi
    Kobayashi, Yoshio
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2024, 39 (04) : 403 - 411
  • [23] Endeavor of exploring mechanisms of myocardial infarction in patients with no standard modifiable cardiovascular risk factors
    Saito, Yuichi
    Kobayashi, Yoshio
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 429
  • [24] Trends and subtypes of acute myocardial infarction and modifiable risk factors in Chinese young adults hospitalized with first acute myocardial infarction
    左惠娟
    ChinaMedicalAbstracts(InternalMedicine), 2021, 38 (04) : 213 - 213
  • [25] Repeated measures of modifiable atherosclerotic risk factors over time and risk of myocardial infarction and venous thrombosis
    Smabrekke, B.
    Rinde, L. B.
    Hald, E. M.
    Vik, A.
    Wilsgaard, T.
    Njolstad, I
    Mathiesen, E.
    Braekkan, S. K.
    Hansen, J-B
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 191 - 191
  • [26] A study of clinical profile and assess the modifiable and non-modifiable risk factors of acute myocardial infarction in young adults
    Mani, Shobana
    Kalavakolanu, Sharada Sivaram
    Piramanayagam, Arunachalam
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 306 - 311
  • [27] Gene-Gene and Gene-Clinical Factors Interaction in Acute Myocardial Infarction: A New Detailed Risk Chart
    Licastro, F.
    Chiappelli, M.
    Porcellini, E.
    Campo, G.
    Buscema, M.
    Grossi, E.
    Garoia, F.
    Ferrari, R.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (07) : 783 - 788
  • [28] PAI-1 gene polymorphism and modifiable risk factors of coronary artery disease
    Saber-Ayad, M. M.
    Latif, I.
    Mahmoud, S.
    Salah, Y.
    Ramadan, Y.
    Taher, E.
    Shafy, S.
    Marrie, A.
    Ghaleb, H.
    Mokhtar, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 1000 - 1000
  • [29] Diuretic-gene interaction and the risk of myocardial infarction and stroke
    Schelleman, H.
    Klungel, O. H.
    Witteman, J. C. M.
    Breteler, M. M. B.
    Hofman, A.
    van Duijn, C. M.
    de Boer, A.
    Stricker, Bhch
    PHARMACOGENOMICS JOURNAL, 2007, 7 (05): : 346 - 352
  • [30] Role of inflammation and cholesterol efflux in myocardial infarction patients without standard modifiable risk factors
    Roule, V
    Beygui, F.
    Guerin, M.
    Materne, C.
    Procopi, N.
    Rahoual, G.
    Guedeney, P.
    Zeitouni, M.
    Kerneis, M.
    Montalescot, G.
    Silvain, J.
    EUROPEAN HEART JOURNAL, 2024, 45
12345